CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 260 filers reported holding CRISPR THERAPEUTICS AG in Q1 2020. The put-call ratio across all filers is 0.73 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,325 | -9.7% | 61,559 | +14.0% | 0.01% | -16.7% |
| Q1 2024 | $3,681 | +26.1% | 53,999 | +15.8% | 0.01% | +20.0% |
| Q4 2023 | $2,918 | +60.6% | 46,616 | +16.5% | 0.01% | +25.0% |
| Q3 2023 | $1,817 | -21.2% | 40,023 | -2.5% | 0.00% | -20.0% |
| Q2 2023 | $2,305 | +26.4% | 41,061 | +1.8% | 0.01% | +25.0% |
| Q1 2023 | $1,824 | -12.1% | 40,341 | -21.0% | 0.00% | -20.0% |
| Q4 2022 | $2,076 | -100.0% | 51,084 | -52.4% | 0.01% | -72.2% |
| Q3 2022 | $7,013,000 | +148.2% | 107,328 | +130.8% | 0.02% | +157.1% |
| Q2 2022 | $2,825,000 | +4.4% | 46,498 | +7.8% | 0.01% | +16.7% |
| Q1 2022 | $2,706,000 | +0.9% | 43,114 | +21.8% | 0.01% | 0.0% |
| Q4 2021 | $2,681,000 | -37.6% | 35,383 | -7.8% | 0.01% | -45.5% |
| Q3 2021 | $4,297,000 | -24.2% | 38,393 | +9.6% | 0.01% | -21.4% |
| Q2 2021 | $5,668,000 | +54.4% | 35,015 | +16.2% | 0.01% | +40.0% |
| Q1 2021 | $3,672,000 | -13.9% | 30,140 | +8.2% | 0.01% | -23.1% |
| Q4 2020 | $4,266,000 | +106.4% | 27,865 | +12.7% | 0.01% | +85.7% |
| Q3 2020 | $2,067,000 | +12.6% | 24,718 | -1.0% | 0.01% | 0.0% |
| Q2 2020 | $1,835,000 | -1.7% | 24,975 | -43.3% | 0.01% | -22.2% |
| Q1 2020 | $1,867,000 | +0.4% | 44,039 | +44.2% | 0.01% | +28.6% |
| Q4 2019 | $1,859,000 | +149.2% | 30,532 | +67.7% | 0.01% | +133.3% |
| Q3 2019 | $746,000 | -11.1% | 18,201 | +2.2% | 0.00% | -25.0% |
| Q2 2019 | $839,000 | +39.6% | 17,815 | +5.9% | 0.00% | +33.3% |
| Q1 2019 | $601,000 | +65.1% | 16,829 | +32.1% | 0.00% | +50.0% |
| Q4 2018 | $364,000 | -38.3% | 12,741 | -4.3% | 0.00% | -33.3% |
| Q3 2018 | $590,000 | -18.8% | 13,318 | +7.6% | 0.00% | -25.0% |
| Q2 2018 | $727,000 | +176.4% | 12,373 | +114.3% | 0.00% | +300.0% |
| Q1 2018 | $263,000 | – | 5,773 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 508,558 | $82,330,000 | 27.28% |
| Valiant Capital Management, L.P. | 307,700 | $49,814,000 | 3.74% |
| NEA Management Company, LLC | 1,590,002 | $257,405,000 | 3.35% |
| NIA IMPACT ADVISORS, LLC | 39,891 | $6,458,000 | 3.15% |
| Ikarian Capital, LLC | 200,000 | $32,379,000 | 2.62% |
| Soleus Capital Management, L.P. | 103,114 | $16,693,000 | 2.57% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 157,334 | $25,471,000 | 2.47% |
| Capital Impact Advisors, LLC | 45,440 | $7,356,000 | 2.37% |
| ARK Investment Management | 7,776,119 | $1,258,876,000 | 2.34% |
| Sassicaia Capital Advisers LLC | 13,513 | $2,188,000 | 2.28% |